Riskpilot← Back to searchSign inGet full accessCardioren Consulting AB
ABActiveOrg 5591220248Orrvägen 1Medical specialists activities · NACE 8622Est. 20170 employees
Revenue 2024
SEK 1,2M
+4% vs 2023
EBITDA margin
71.8%
-3% vs 2023
Equity ratio
93.1%
Financial strength
Net profit 2024
SEK 1,1M
+29% vs 2023
| Revenue | SEK 1,2M | +4% |
| EBITDA | SEK 854K | -3% |
| Net profit | SEK 1,1M | +29% |
| Total assets | SEK 3,7M | +38% |
| Equity | SEK 3,4M | +38% |
| Employees | 0 | — |
Legal name
Cardioren Consulting AB
Org number
5591220248
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 augusti 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Specialistläkarens konsultversamhet inom vård av hjärt och njursjukdomar.
Address
Orrvägen 1
Email
nikolai.fedchenko@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 442 | 513 | 682 | 1 140 | 1 189 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 326 | 335 | 435 | 876 | 854 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 326 | 335 | 435 | 876 | 854 |
| Net financials | 138 | 155 | 301 | 246 | 594 |
| Profit before tax | 464 | 491 | 735 | 1 121 | 1 447 |
| Tax | −100 | −101 | −150 | −232 | −301 |
| Net profit | 364 | 390 | 585 | 889 | 1 146 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 296 | 1 725 | 2 116 | 2 660 | 3 664 |
| Equity | 1 182 | 1 572 | 1 977 | 2 471 | 3 413 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 114 | 153 | 140 | 189 | 251 |
| Total debt | 114 | 153 | 140 | 189 | 251 |
EBITDA margin
71.8%
This company
15.8%
Market median
+354% vs market
20202024
Equity ratio
93.1%
This company
38.2%
Market median
+144% vs market
20202024
Return on equity
33.6%
This company
18.4%
Market median
+83% vs market
20202024
Net profit margin
96.4%
This company
8.1%
Market median
+1090% vs market
20202024
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
20202024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cardioren Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Fedchenko | Deputy Board Member | 0 companies |
| Anton Fedchenko | Deputy Board Member | 0 companies |
| Elena Fedchenko | Board of Directors | 0 companies |
| Nikolai Fedchenko | Chairman | 0 companies |